Last reviewed · How we verify

Ricobendazole — Competitive Intelligence Brief

Ricobendazole (albendazole sulfoxide) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: albendazole sulfoxide. Area: Other.

marketed albendazole sulfoxide Tubulin alpha chain Other Live · refreshed every 30 min

Target snapshot

Ricobendazole (albendazole sulfoxide).

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ricobendazole TARGET albendazole sulfoxide marketed albendazole sulfoxide Tubulin alpha chain

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (albendazole sulfoxide class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ricobendazole — Competitive Intelligence Brief. https://druglandscape.com/ci/albendazole-sulfoxide. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: